<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Undernutrition in pregnancy: Evaluation, management, and outcome in resource-limited areas</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Undernutrition in pregnancy: Evaluation, management, and outcome in resource-limited areas</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Undernutrition in pregnancy: Evaluation, management, and outcome in resource-limited areas</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">D Taylor Hendrixson, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark J Manary, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Indi Trehan, MD, MPH, DTM&amp;H</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">L Lewis Wall, MD, DPhil</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lynn L Simpson, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vanessa A Barss, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 20, 2021.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3757382909"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Undernutrition in pregnancy can be defined as a maternal nutritional state in which nutrient stores and macronutrient/micronutrient intake are less than that needed to achieve optimal maternal, fetal, and newborn outcomes. It is also a risk factor for development of adverse outcomes. Thus, identification and management of maternal undernutrition is important.</p><p>This topic will discuss issues related to both macronutrient and micronutrient deficiencies common to pregnancies in resource-limited settings. General issues regarding nutrition in pregnancy and issues related to malnutrition in children in resource-limited areas are reviewed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/453.html" rel="external">"Nutrition in pregnancy: Dietary requirements and supplements"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5883.html" rel="external">"Malnutrition in children in resource-limited settings: Clinical assessment"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/117772.html" rel="external">"Management of moderate acute malnutrition in children in resource-limited settings"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/113959.html" rel="external">"Management of uncomplicated severe acute malnutrition in children in resource-limited settings"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5901.html" rel="external">"Management of complicated severe acute malnutrition in children in resource-limited settings"</a>.)</p><p></p><p class="headingAnchor" id="H1494377006"><span class="h1">CONSEQUENCES OF MATERNAL UNDERNUTRITION</span><span class="headingEndMark"> — </span>The majority of direct experimental evidence regarding effects of maternal undernutrition on offspring development is derived from animal studies, given the ethical concerns of conducting this research in humans [<a href="#rid1">1,2</a>]. However, some data from human epidemiologic studies are available and show that, in general, maternal undernutrition impairs placental development, including a reduction in placental size, alterations in histomorphology, and reduction of blood flow, which can diminish nutrient delivery to the fetus [<a href="#rid3">3</a>]. In addition to fetal growth restriction, maternal undernutrition has been associated with low birth weight (LBW) and preterm birth, plus the short- and long-term complications associated with these outcomes, and with maternal complications, such as life-threatening hemorrhage [<a href="#rid4">4-7</a>]. (See  <a class="medical medical_review" href="/d/html/5062.html" rel="external">"Infants with fetal (intrauterine) growth restriction"</a> and  <a class="medical medical_review" href="/d/html/4966.html" rel="external">"Preterm birth: Definitions of prematurity, epidemiology, and risk factors for infant mortality"</a> and  <a class="medical medical_review" href="/d/html/4965.html" rel="external">"Overview of short-term complications in preterm infants"</a> and  <a class="medical medical_review" href="/d/html/5033.html" rel="external">"Overview of the long-term complications of preterm birth"</a>.)</p><p>The Barker hypothesis postulates that undernutrition during critical periods of pregnancy alters fetal morphology and physiology in permanent ways ("programming"). While these alterations provide short-term advantages to survival in utero, they restrict the individual's ability to adapt to a different environment after birth. Numerous epidemiologic studies of populations that have experienced famine during pregnancy have reported offspring of such pregnancies are at increased risk for ischemic heart disease and related disorders in adult life [<a href="#rid8">8-10</a>]. (See  <a class="medical medical_review" href="/d/html/5062.html" rel="external">"Infants with fetal (intrauterine) growth restriction", section on 'Adult chronic disorders'</a>.)</p><p>The processes by which maternal undernutrition exerts fetal effects are not strictly caloric; they may also involve scarcities of specific micronutrients at critical stages in embryonic and fetal development [<a href="#rid11">11</a>]. Many specific micronutrient deficiencies can be mitigated by supplementation.</p><p>For example:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10047" href="/d/drug information/10047.html" rel="external">Vitamin A</a> deficiency may cause night blindness, and supplementation of vitamin A is recommended by the World Health Organization (WHO) in areas where ≥5 percent of females have a history of night blindness in their most recent pregnancy or if ≥20 percent of pregnant people have a serum retinol level &lt;0.70 micromol/L [<a href="#rid12">12</a>]. Vitamin A supplementation does not reduce perinatal or maternal mortality [<a href="#rid13">13</a>]. (See  <a class="medical medical_review" href="/d/html/2571.html" rel="external">"Overview of vitamin A"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Calcium deficiency has been associated with hypertension and preterm birth, and high-dose calcium supplementation (&gt;1 gram/day) in pregnant people with low-calcium diets has been associated with reduced risk of preeclampsia and preterm birth [<a href="#rid14">14</a>]. (See <a class="local">'Calcium'</a> below and  <a class="medical medical_review" href="/d/html/6817.html" rel="external">"Preeclampsia: Prevention", section on 'Calcium supplementation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Zinc deficiency has been associated with postpartum hemorrhage due to atony, LBW, and preterm birth [<a href="#rid15">15,16</a>]. Although a Cochrane review reported a 14 percent relative reduction in preterm birth for patients receiving zinc supplementation compared with placebo in low-income settings and areas of high perinatal mortality [<a href="#rid17">17</a>], the WHO only recommends zinc supplementation in research settings [<a href="#rid12">12</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Iron deficiency anemia during pregnancy may be attributed to poor dietary intake of iron, inadequate iron absorption, and blood loss from intestinal helminths or malaria [<a href="#rid18">18</a>]. Iron supplementation reduces the frequency of maternal anemia and may have other fetal/neonatal benefits as well. (See <a class="local">'Iron and folic acid'</a> below and  <a class="medical medical_review" href="/d/html/115637.html" rel="external">"Anemia in pregnancy", section on 'Iron deficiency'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Periconceptional <a class="drug drug_general" data-topicid="8475" href="/d/drug information/8475.html" rel="external">folic acid</a> supplementation decreases the occurrence and recurrence of neural tube defects. Supplementation also reduces the maternal risk of developing anemia since the increase in red blood cell production during pregnancy creates an increased demand for folate. (See  <a class="medical medical_review" href="/d/html/423.html" rel="external">"Preconception and prenatal folic acid supplementation"</a> and  <a class="medical medical_review" href="/d/html/429.html" rel="external">"Maternal adaptations to pregnancy: Hematologic changes"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Iodine deficiency has potentially harmful effects, such as maternal and fetal/neonatal hypothyroidism. Low iodine intake can occur in areas where non-iodized salt and seafood low in iodine are consumed. (See  <a class="medical medical_review" href="/d/html/453.html" rel="external">"Nutrition in pregnancy: Dietary requirements and supplements", section on 'Iodine'</a>.)</p><p></p><p class="headingAnchor" id="H1519353174"><span class="h1">ANTHROPOMETRIC DIAGNOSIS OF UNDERNUTRITION</span><span class="headingEndMark"> — </span>Both mid-upper arm circumference (MUAC) and body mass index (BMI) are used to identify undernutrition in pregnancy. These measurements are easily reproducible, achievable in resource-limited settings, and correlate with clinically significant adverse outcomes. In a meta-analysis of pregnant patients in humanitarian conflict zones, no minimum values for BMI by gestational age could be established because of insufficient data [<a href="#rid19">19</a>]. The advantages of MUAC included a relatively strong association with LBW, narrow range of cut-off values, simplicity of measurement (important in humanitarian settings), and prior knowledge of gestational age is unnecessary.</p><p class="headingAnchor" id="H2849740534"><span class="h2">Mid-upper arm circumference</span><span class="headingEndMark"> — </span>A MUAC &lt;23 cm is a reasonable threshold to identify maternal undernutrition as it is reproducible, reflects maternal fat stores and lean mass, correlates strongly with low BMI [<a href="#rid19">19-21</a>], and predicts the risk of delivering a low birth weight infant (LBW) [<a href="#rid19">19,21-23</a>]. Further research is needed to determine if MUAC cutoff values should differ between different geographic regions, but available data suggest a MUAC &lt;23 cm can be applied worldwide [<a href="#rid24">24</a>]. The Sphere guidelines recommend using a MUAC cutoff range of 21 to 23 cm for maternal enrollment into supplementary feeding programs, and MUAC &lt;21 cm in humanitarian emergencies when resources are severely limited [<a href="#rid25">25</a>]. Some countries have guidelines for the appropriate MUAC cutoff in various clinical settings, and these should be consulted where available.</p><p>The World Health Organization (WHO) does not have standard recommendations regarding MUAC use during pregnancy, but the United Nations Children's Fund (UNICEF) and several other international organizations use it as a screening tool for children. </p><p class="headingAnchor" id="H2704740703"><span class="h2">Low body mass index</span><span class="headingEndMark"> — </span>Some programs use a BMI cutoff of 18.5 kg/m<sup>2</sup> for undernutrition as &lt;18.5 kg/m<sup>2</sup> is considered underweight for a nonpregnant female [<a href="#rid26">26</a>] and, in pregnancy, associated with an increased risk for LBW [<a href="#rid27">27</a>] and preterm birth [<a href="#rid28">28</a>]. A BMI of 16 to 18.49 kg/m<sup>2</sup> is considered moderate undernutrition; a BMI &lt;16.0 kg/m<sup>2</sup> is considered severe undernutrition and has a particularly high risk for LBW and preterm birth. Of note, although BMI is readily determined in resource-rich countries, the staff in many resource-limited countries may have difficulty determining BMI compared with MUAC.</p><p class="headingAnchor" id="H25990648"><span class="h2">Other approaches</span></p><p class="headingAnchor" id="H145013707"><span class="h3">Low gestational weight gain</span><span class="headingEndMark"> — </span>Specific guidelines for appropriate gestational weight gain have been published by the National Academy of Medicine (formerly the Institute of Medicine [IOM]). Over the course of a term pregnancy, gestational weight gain below the levels recommended by these guidelines  (<a class="graphic graphic_table graphicRef75820" href="/d/graphic/75820.html" rel="external">table 1</a>) increases the risk for small for gestational age infants [<a href="#rid29">29,30</a>]. When considered in terms of weekly maternal weight gain, weight gain &lt;300 grams/week correlates with an increased risk of LBW [<a href="#rid19">19</a>]. The LifeCycle Project-Maternal Obesity and Childhood Outcomes Study Group has published slightly different appropriate gestational weight gain ranges, with adjustments that account for preeclampsia, gestational diabetes, and different degrees of obesity. (See  <a class="medical medical_review" href="/d/html/441.html" rel="external">"Gestational weight gain", section on '2009 IOM weight gain recommendations'</a> and  <a class="medical medical_review" href="/d/html/441.html" rel="external">"Gestational weight gain", section on 'Subsequent data that may inform guidance for gestational weight gain'</a>.)</p><p>Specific recommendations are needed for appropriate gestational weight gain in Asian populations [<a href="#rid31">31</a>] as they are more likely to be classified as having inadequate gestational weight gain when universal criteria are applied. Although there is no clear cutoff value for maternal weight, &lt;45 kg at any gestational age suggests a high risk of LBW in Asian countries and could be used as an enrollment criterion in feeding programs [<a href="#rid19">19</a>]. </p><p>Maternal weight for gestational age Z-score charts are available and have been proposed as a new tool to more accurately predict needed weight gain in underweight patients [<a href="#rid32">32-34</a>]. Undernutrition is defined as a weight for gestational age Z-score more than two standard deviations below the mean. However, in resource-limited settings, an accurate estimate of gestational age is often not possible, making this measurement difficult to implement effectively.</p><p class="headingAnchor" id="H3284053940"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Undernutrition in pregnancy remains a significant problem throughout low- and middle-income countries (LMICs). Rates of underweight pregnant people are up to 10 times higher in the poorest countries when compared with the richest countries [<a href="#rid35">35</a>]. The United Nations Children's Fund (UNICEF) 2018 Global Nutrition Report noted that 9.7 percent of pregnant people were underweight as defined by body mass index [<a href="#rid36">36</a>]. A 2019 meta-analysis estimated maternal undernutrition affected up to 23.5 percent of pregnant people in sub-Saharan Africa [<a href="#rid37">37</a>]. Since 2000, the overall rate has declined only slightly, and the rate in adolescent females has increased. A 2021 analysis of trends of low BMI among young and adult females in 40 LMICs reported the prevalence decreased among the adults but remained unchanged among the 15 to 19 year olds [<a href="#rid38">38</a>].</p><p>Undernutrition is commonly associated with both being underweight and inadequate gestational weight gain. In a meta-analysis of studies from sub-Saharan Africa, up to 20 percent of pregnant people were underweight, and gestational weight gain was inadequate in 67 to 98 percent of these individuals [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H4139581174"><span class="h1">RISK FACTORS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Adolescents are at high risk for nutritional depletion as the mother and fetus are competing for nutrients to support adequate growth and development [<a href="#rid40">40</a>]. Preconceptional nutrition should be optimized; however, many adolescents in resource-limited settings have inadequate nutrient reserves elevating their risk for adverse outcomes [<a href="#rid41">41</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients carrying twins or higher order multiple gestations have higher nutritional requirements than those carrying singleton pregnancies. The higher caloric and micronutrient requirements place them at an up to twofold higher risk for developing undernutrition and micronutrient deficiencies [<a href="#rid37">37</a>]. As an example, the maternal basal metabolic rate in twin pregnancies increases approximately 10 percent above that in singleton pregnancies [<a href="#rid42">42</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Food insecurity is an established risk factor for undernutrition at all life stages, including pregnancy. Food insecurity has increased since 2014, with the sharpest increase in 2020 [<a href="#rid43">43</a>]. The Food and Agriculture Organization of the United Nations (FAO) estimates that nearly 12 percent of the world's population (928 million people) is exposed to severe food insecurity, with the prevalence of moderate or severe food insecurity 10 percent higher among females than among males [<a href="#rid43">43</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Residing in rural areas confers a 2.6-fold higher risk of undernutrition in pregnancy [<a href="#rid37">37</a>]. This may be due to less access to health care and nutritious foods in rural compared with urban areas.</p><p></p><p class="headingAnchor" id="H804818747"><span class="h1">NUTRITIONAL REQUIREMENTS DURING PREGNANCY</span></p><p class="headingAnchor" id="H807825280"><span class="h2">General dietary recommendations</span><span class="headingEndMark"> — </span>Pregnancy is a time of increased nutritional requirements. For example, caloric requirements are increased by 340 to 450 kcal/day during the second and third trimesters and there are increased requirements for some micronutrients. General nutritional requirements during pregnancy are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/453.html" rel="external">"Nutrition in pregnancy: Dietary requirements and supplements"</a>.)</p><p class="headingAnchor" id="H3884194052"><span class="h2">Recommendations for underweight patients</span><span class="headingEndMark"> — </span>There are no formal dietary recommendations available for pregnant patients with undernutrition, regardless of country of residence. Most intake recommendations are based on the National Academy of Medicine (formerly the Institute of Medicine [IOM]) report on nutrition during pregnancy [<a href="#rid44">44</a>] and report on weight gain during pregnancy [<a href="#rid4">4</a>].</p><p>Although recommended dietary allowances have been developed by the National Academy of Medicine and are often used as a guide for dietary intake in the United States and Canada [<a href="#rid45">45-48</a>] (see  <a class="medical medical_review" href="/d/html/453.html" rel="external">"Nutrition in pregnancy: Dietary requirements and supplements"</a>), these recommendations may not apply to patients who have preexisting micronutrient deficiencies and who require extra supplementation to recover. The World Health Organization (WHO), United Nations Children's Fund (UNICEF), and World Food Programme (WFP) have developed recommendations for micronutrient supplementation in low-income and emergency settings [<a href="#rid49">49,50</a>]. The recommended values of each micronutrient are shown in the table  (<a class="graphic graphic_table graphicRef122101" href="/d/graphic/122101.html" rel="external">table 2</a>).</p><p>Clinical signs of micronutrient deficiencies are often nonspecific and may not be identified until whole body stores are severely depleted. This has been referred to as "hidden hunger" and affects up to two billion of the world's population, with high prevalence among pregnant people [<a href="#rid51">51,52</a>]. The most common micronutrient deficiencies are for iron, <a class="drug drug_general" data-topicid="10047" href="/d/drug information/10047.html" rel="external">vitamin A</a>, calcium, and zinc. For example, up to 40 percent of pregnant people in resource-limited settings suffer from anemia [<a href="#rid53">53</a>], and iron deficiency may account for up to 50 percent of global cases of anemia [<a href="#rid54">54</a>]. Vitamin A deficiency is estimated to affect 9.8 million pregnant people and 15.3 percent of pregnant people in at-risk populations [<a href="#rid55">55</a>].</p><p class="headingAnchor" id="H1477809"><span class="h1">EVALUATION FOR UNDERNUTRITION</span><span class="headingEndMark"> — </span>An important component of routine prenatal care for all pregnant patients is a thorough, context-specific nutritional assessment [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/d/html/446.html" rel="external">"Prenatal care: Initial assessment"</a> and  <a class="medical medical_review" href="/d/html/83303.html" rel="external">"Prenatal care: Second and third trimesters"</a>.)</p><p class="headingAnchor" id="H3242660890"><span class="h2">Dietary evaluation</span><span class="headingEndMark"> — </span>A thorough evaluation of dietary intake and diversity is warranted in all pregnant patients. There are a number of approaches to this assessment, including 24-hour dietary recall, food diary, and food frequency questionnaires, which are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/5366.html" rel="external">"Dietary assessment in adults"</a>.)</p><p class="headingAnchor" id="H1894694322"><span class="h2">Assessment of food security</span><span class="headingEndMark"> — </span>Assessment of food security using standard tools is recommended. The Household Food Insecurity Access Scale (HFIAS) is a nine question tool validated across multiple settings that can be used for screening in pregnant patients  (<a class="graphic graphic_table graphicRef122102" href="/d/graphic/122102.html" rel="external">table 3</a>) [<a href="#rid56">56</a>].</p><p class="headingAnchor" id="H2837796517"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>An anthropometric assessment should be performed at each prenatal visit. This includes review of baseline height, prepregnancy weight and body mass index (BMI), current weight and BMI, and mid-upper arm circumference (MUAC).</p><p>In addition, undernourished patients should be evaluated for clinical instability, which may include hypotension, hypothermia, tachycardia, tachypnea, and inability to eat food. Any patient identified as unstable should be referred for inpatient evaluation and management.</p><p>Evaluation for physical signs and symptoms of micronutrient deficiencies is required as many of these individuals will have multiple micronutrient deficiencies  (<a class="graphic graphic_table graphicRef126245" href="/d/graphic/126245.html" rel="external">table 4</a>).</p><p class="headingAnchor" id="H1159185482"><span class="h2">Laboratory examination</span><span class="headingEndMark"> — </span>Prenatal laboratory examination is guided by local and national recommendations and available resources. Other laboratory tests are ordered based on suspicious clinical findings rather than undernutrition alone. (See  <a class="medical medical_review" href="/d/html/446.html" rel="external">"Prenatal care: Initial assessment", section on 'Laboratory tests'</a> and  <a class="medical medical_review" href="/d/html/83303.html" rel="external">"Prenatal care: Second and third trimesters"</a>.)</p><p class="headingAnchor" id="H3203957514"><span class="h1">TREATMENT OF UNDERNUTRITION</span></p><p class="headingAnchor" id="H2522963904"><span class="h2">Basic principles</span><span class="headingEndMark"> — </span>Pregnant patients identified as undernourished should receive nutritional education on selecting and increasing intake of energy-dense, locally available foods, when food is secure and available [<a href="#rid12">12</a>]. Educational programs may include recipes for these foods. This educational approach has been demonstrated to be effective in increasing protein intake and reducing the risk of preterm birth and low birth weight (LBW) [<a href="#rid57">57,58</a>].</p><p class="headingAnchor" id="H119728243"><span class="h2">Use and types of supplements</span><span class="headingEndMark"> — </span>Provision of supplementation should begin in the preconception period or as early in pregnancy as possible to maximize maternal and neonatal benefits [<a href="#rid59">59</a>].</p><p>If locally available foods are not sufficient to correct undernutrition, which is common in resource-limited settings, then specially formulated products, including multiple micronutrient supplements (MMNs), fortified blended flours, or lipid-based nutrient supplements (LNS), may be used to address both macronutrient and micronutrient deficiencies [<a href="#rid49">49</a>]. Micronutrient supplements should be used in conjunction with locally available, nutrient-dense foods or with balanced energy and protein supplements to provide required macronutrients. Choice of supplement is largely based on product availability.</p><p class="headingAnchor" id="H1865937854"><span class="h3">Balanced energy and protein supplementation</span><span class="headingEndMark"> — </span>Balanced energy and protein supplements are generally considered to be those products that provide less than 25 percent of energy from protein. The World Health Organization (WHO) recommends them for pregnant people with undernutrition [<a href="#rid12">12</a>] based on evidence of a possible modest reduction in the rates of stillbirth and small for gestational age infant (SGA) in a meta-analysis of randomized trials (stillbirth: risk ratio [RR] 0.60, 95% CI 0.39-0.94; SGA: RR 0.79, 95% CI 0.69-0.90) [<a href="#rid57">57</a>]. The same meta-analysis did not support use of high-protein supplementation; thus, these supplements are not recommended to improve birth outcomes [<a href="#rid12">12</a>]. A subsequent systematic review of studies conducted in low- and middle-income countries (LMICs) also found that balanced energy and protein supplementation reduced the incidence of stillbirth (RR 0.39, 95% CI 0.19-0.80) and LBW (RR 0.60, 95% CI 0.41-0.86) [<a href="#rid60">60</a>].</p><p>There is diversity in the type of foods used to deliver balanced protein and energy supplementation, including beverages, biscuits, milk products, and enriched breads [<a href="#rid61">61</a>]. Many of these products are not commercially available as they have been developed for local use. Commercially available products include high-energy biscuits and fortified spreads. Nutrient content of these products is summarized in the table  (<a class="graphic graphic_table graphicRef126244" href="/d/graphic/126244.html" rel="external">table 5</a>). The type and amount of supplement should be chosen based on local availability of products, acceptability of the product among the target population, and the nutrient deficiency targeted [<a href="#rid12">12</a>].</p><p class="headingAnchor" id="H2154175498"><span class="h3">Fortified blended flours</span><span class="headingEndMark"> — </span>Fortified blended flour products are designed to provide 10 to 15 percent of energy from protein, 20 to 25 percent of energy from fat, and two-thirds of the daily requirements for micronutrients [<a href="#rid62">62</a>]. Several fortified blended flour products are available for the treatment of undernutrition [<a href="#rid63">63</a>]. Most were developed for use in infants and children but can be used for supplemental nutrition in pregnancy in appropriate contexts [<a href="#rid49">49</a>]. Use of a fortified flour blend in pregnancy has been associated with reductions in both maternal anemia and preterm birth [<a href="#rid64">64</a>] and increased birth weight [<a href="#rid65">65</a>].</p><p>Super Cereal is the fortified blended flour product recommended by the World Food Programme (WFP) and the United States Agency for International Development (USAID). Several formulations of Super Cereal are available and include a grain product of corn, wheat, or rice added to soya, with vitamin and mineral fortification. Corn-soya blended flour is the most widely used for undernourished pregnant people; however, rice-soya and wheat-soya are appropriate products if more acceptable in the target population. Locally produced fortified blended flours have also been developed for use in a number of countries. Most of these products are based on the Super Cereal formulation but with alterations in the grain components to utilize locally available ingredients. The nutrient composition of Super Cereal is shown in the table  (<a class="graphic graphic_table graphicRef126243" href="/d/graphic/126243.html" rel="external">table 6</a>).</p><p>The WFP and USAID recommend a ration of 200 to 250 grams of Super Cereal mixed with 25 grams of oil daily. This 250 gram ration includes provision for sharing [<a href="#rid66">66</a>]. The product is prepared as a porridge or gruel by mixing 40 grams of flour with 250 mL of clean water and simmering for 5 to 10 minutes.</p><p>Some negative aspects of fortified blended flours is that they require cooking and teaching of proper preparation of the product. Preparation requires the use of clean boiling water, which increases the time burden on the individual. Contamination of the product can occur during the cooking process, and it can spoil if not consumed within a few hours of preparation. Additionally, most flour products have lower energy density than lipid-based supplements, so they require larger amounts to be ingested to meet caloric needs. On the other hand, fortified blended flours are often similar to locally consumed foods and thus largely acceptable for consumption in target populations.</p><p class="headingAnchor" id="H4200800632"><span class="h3">Lipid-based nutrient supplements</span><span class="headingEndMark"> — </span>LNS are designed to deliver a food-safe, standard amount of calories and nutrients to individuals with undernutrition. A 2018 meta-analysis of four randomized trials of the use of LNS for the treatment of undernutrition in pregnancy identified a small benefit in infant weight and length compared with traditional iron-folic acid supplementation and/or MMNs [<a href="#rid67">67</a>]. No trials using LNS in emergency settings were available at the time of the review. In a subsequent meta-analysis of 11 randomized trials, LNS use during pregnancy significantly reduced the risks of LBW, SGA, and stunting compared with fortified corn-soya blend, iron-folic acid, and/or MMNs [<a href="#rid68">68</a>].</p><p>The majority of energy in LNS is provided by lipids, but the quantity of LNS prescribed varies among products and may be small (SQ-LNS), medium (MQ-LNS), or large (LQ-LNS). LQ-LNS are designed for treatment of severe undernutrition, while MQ-LNS are designed for treatment of moderate undernutrition. SQ-LNS have been used for the prevention of undernutrition and provide only a fraction of daily caloric needs but the majority of micronutrient requirements [<a href="#rid69">69,70</a>].</p><p>LNS products provide protein, lipids, fatty acids, and multiple micronutrients. The composition of these products varies but typically includes vegetable oil, peanut (groundnut) paste, milk powder, sugar, and micronutrients and vitamins. There is no standard composition for use in pregnant people, although many programs have designed them to meet the micronutrient needs required during pregnancy [<a href="#rid69">69,71-74</a>]. Commercial products are also available  (<a class="graphic graphic_table graphicRef126242" href="/d/graphic/126242.html" rel="external">table 7</a>).</p><p>No standardized international guidance is available on dosing; most programs employ a daily ration of ready-to-use supplementary foods to provide an additional 118 to 1000 kcal [<a href="#rid69">69,71-73,75</a>]. Higher dose supplementation does not appear to be superior to lower dose rations. As there is no consensus on dosing and no clear evidence to support one regimen over another, we recommend rations of one to two sachets of LNS (providing 500 to 1000 kcal) daily as this may be the easiest to deliver operationally.</p><p class="headingAnchor" id="H874043081"><span class="h3">Multiple micronutrient supplements</span><span class="headingEndMark"> — </span>Micronutrient deficiencies are common among pregnant people in resource-limited settings. MMNs are point-of-use fortification packets formulated to deliver standard concentrations of common micronutrients. They can reduce deficiencies but may not eliminate them [<a href="#rid76">76</a>]. The United Nations International Multiple Micronutrient Preparation (UNIMMAP) is a commonly recommended composition  (<a class="graphic graphic_table graphicRef122103" href="/d/graphic/122103.html" rel="external">table 8</a>) [<a href="#rid77">77</a>].</p><p>In a 2019 meta-analysis of randomized trials in pregnancy comparing MMNs with supplements of iron with or without <a class="drug drug_general" data-topicid="8475" href="/d/drug information/8475.html" rel="external">folic acid</a>, MMNs reduced the risk for LBW (187 versus 212 per 1000, RR 0.88, 95% CI 0.85-0.91) and SGA (310 versus 337 per 1000, RR 0.92, 95% CI 0.88-0.97) [<a href="#rid78">78</a>]. Risks for preterm birth and perinatal mortality were similar in both groups. Long-term trials have found that MMNs consumed during pregnancy also have benefits extending into early childhood, such as improved body weight, mid-upper arm circumference, head circumference [<a href="#rid79">79</a>], and enhanced infant antibody responses to the diphtheria-tetanus-pertussis (DTP) vaccine [<a href="#rid80">80</a>].</p><p>WHO guidelines recommend use of MMNs in pregnant people receiving antenatal care in any health care facility or community-based setting, in the context of rigorous research [<a href="#rid81">81</a>]. The evidence for this recommendation was mainly derived from LMICs, thus they state that applicability to high-income countries or to populations not at risk of micronutrient (eg, adequate diet, food fortification programs) is unclear.</p><p class="headingAnchor" id="H2767260058"><span class="h3">Other supplements</span></p><p class="headingAnchor" id="H1378199448"><span class="h4">Iron and folic acid</span><span class="headingEndMark"> — </span>The WHO recommends daily iron and <a class="drug drug_general" data-topicid="8475" href="/d/drug information/8475.html" rel="external">folic acid</a> supplementation with 30 to 60 mg of elemental iron and 400 micrograms of folic acid [<a href="#rid12">12</a>] or once weekly supplementation with 120 mg of elemental iron and 2800 micrograms of folic acid for pregnant people [<a href="#rid12">12</a>]. Alternate-day iron dosing is becoming more common since less frequent dosing reduces adverse effects and improves iron uptake. In a systematic review of periconception interventions in LMICs, iron plus folic acid supplementation reduced the risk of anemia, and folic acid supplementation reduced the risk of neural tube defects [<a href="#rid82">82</a>]. Folic acid has also been associated with increased birth weight and decreased incidence of LBW and SGA [<a href="#rid83">83,84</a>]. (See  <a class="medical medical_review" href="/d/html/115637.html" rel="external">"Anemia in pregnancy", section on 'Prevention of iron deficiency'</a> and  <a class="medical medical_review" href="/d/html/423.html" rel="external">"Preconception and prenatal folic acid supplementation", section on 'Administration'</a>.)</p><p class="headingAnchor" id="H169374463"><span class="h4">Calcium</span><span class="headingEndMark"> — </span>The WHO recommends 1.5 to 2 grams oral elemental calcium daily for pregnant people in populations with low dietary calcium intake to reduce the risk of preeclampsia [<a href="#rid12">12,49</a>]. Calcium supplementation at doses &gt;1 gram/day has been associated with a reduced risk of preterm birth [<a href="#rid58">58</a>], likely related to the reduced risk of preeclampsia. (See  <a class="medical medical_review" href="/d/html/6817.html" rel="external">"Preeclampsia: Prevention", section on 'Calcium supplementation'</a>.)</p><p class="headingAnchor" id="H263734326"><span class="h4">Iodine</span><span class="headingEndMark"> — </span>The WHO and United Nations Children's Fund (UNICEF) recommend iodine supplementation (250 micrograms daily) for pregnant people in countries where less than 20 percent of households have access to iodized salt [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/d/html/453.html" rel="external">"Nutrition in pregnancy: Dietary requirements and supplements", section on 'Iodine'</a>.)</p><p class="headingAnchor" id="H1487127533"><span class="h4">Vitamin A</span><span class="headingEndMark"> — </span>The WHO recommends <a class="drug drug_general" data-topicid="10047" href="/d/drug information/10047.html" rel="external">vitamin A</a> supplementation in areas where ≥5 percent of females had a history of night blindness in their most recent pregnancy or where ≥20 percent of pregnant people have a serum retinol level &lt;0.7 micromol/L [<a href="#rid12">12</a>]. The recommended dose is 10,000 international units daily or 25,000 international units weekly for a minimum of 12 weeks during pregnancy [<a href="#rid12">12</a>]. Vitamin A supplementation in combination with other micronutrients may decrease the risk of LBW [<a href="#rid58">58</a>].</p><p class="headingAnchor" id="H426855477"><span class="h3">Vitamins and other substances that do not need to be supplemented</span><span class="headingEndMark"> — </span>The WHO does not recommend supplementation of vitamins B6, C, D, and E in pregnancy [<a href="#rid12">12,85</a>]. Although deficiencies can have health consequences, there is no evidence to support a benefit of routine use of any of these supplements. (See  <a class="medical medical_review" href="/d/html/13915.html" rel="external">"Vitamin D and extraskeletal health", section on 'Pregnancy outcomes'</a>.)</p><p class="headingAnchor" id="H3607057920"><span class="h3">L-arginine</span><span class="headingEndMark"> — </span>L-arginine is an essential amino acid and precursor to nitric oxide with roles in vascular development and fetal growth. Studies of oral low-dose supplementation in pregnancy have reported potential favorable effects for reducing the incidence of preeclampsia and improving birth outcomes, including higher birth weight and longer gestation [<a href="#rid86">86,87</a>]. L-arginine has been safely administered in pregnancy in several clinical trials but additional research is needed to confirm its effectiveness before widespread adoption of the intervention. </p><p>In addition, the optimal dosing strategy is not well established for use in pregnancy. There is no established guideline for maximum intake of L-arginine. Typical diets in high-income Western settings include 4 to 5 g/day of <a class="drug drug_general" data-topicid="8883" href="/d/drug information/8883.html" rel="external">arginine</a> [<a href="#rid88">88</a>]. Arginine administration appears to be safe up to 20 to 30 g/day [<a href="#rid89">89,90</a>]. Higher doses (&gt;9 g) are associated with increased adverse gastrointestinal symptoms [<a href="#rid91">91</a>]. Trials in pregnancy have included doses ranging from 3 to 30 g/day for varying durations with higher doses typically being administered for shorter durations.</p><p class="headingAnchor" id="H2382514947"><span class="h3">Omega-3 long-chain polyunsaturated fatty acids (LCPUFA)</span><span class="headingEndMark"> — </span>A 2018 Cochrane review reported a reduction in preterm births and a possible reduction in perinatal death and low birth weight among individuals receiving n-3 LCPUFA supplementation during pregnancy [<a href="#rid92">92</a>]. These and other outcome data are reviewed in detail separately. (See  <a class="medical medical_review" href="/d/html/431.html" rel="external">"Fish consumption and marine omega-3 fatty acid supplementation in pregnancy"</a>.)</p><p>The WHO recommends further research prior to widespread implementation of n-3 LCPUFA supplementation [<a href="#rid93">93</a>].</p><p class="headingAnchor" id="H3100057685"><span class="h2">Distribution</span><span class="headingEndMark"> — </span>There are two main approaches to community feeding programs: blanket distribution and targeted distribution.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Blanket distribution</strong> – Blanket distribution provides supplementary food to an entire at-risk population, such as all females of childbearing age or all pregnant and lactating people in a given region. This strategy often aims to prevent development or progression of acute malnutrition. The United Nations High Commissioner for Refugees (UNHCR) recommends implementation of blanket supplementary feeding programs when the rate of undernutrition is ≥15 percent in a population or 10 to 14 percent in a population with aggravating factors  (<a class="graphic graphic_table graphicRef126241" href="/d/graphic/126241.html" rel="external">table 9</a>) [<a href="#rid94">94</a>]. However, this approach is often cost prohibitive because large populations of individuals without acute malnutrition will receive treatment, but it may be highly effective in emergency settings.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Targeted distribution</strong> – Targeted distribution identifies individuals meeting criteria for admission into a feeding program and provides rations to these individuals. This approach seeks to treat existing acute malnutrition. Targeted supplementary feeding is recommended by the UNHCR when global acute malnutrition is 10 to 14 percent or 5 to 9 percent in a population with aggravating factors  (<a class="graphic graphic_table graphicRef126241" href="/d/graphic/126241.html" rel="external">table 9</a>) [<a href="#rid94">94</a>].</p><p></p><p class="headingAnchor" id="H3251141864"><span class="h2">Adjunctive therapies</span><span class="headingEndMark"> — </span>Pregnant women with undernutrition are at increased risk of infection and inflammation, which can lead to preterm birth, thus use of anti-infection therapies can improve pregnancy and newborn outcome.</p><p class="bulletIndent1"><span class="glyph">●</span>Prevention of malaria by mosquito avoidance and intermittent preventive treatment in pregnancy (IPTp) and treatment of malarial infection are established components of prenatal care in areas where malaria is endemic. (See  <a class="medical medical_review" href="/d/html/4812.html" rel="external">"Malaria in pregnancy: Prevention and treatment"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Empiric anthelmintic treatment is a component of strategies to improve maternal nutrition in areas where helminths are endemic and anemia is prevalent [<a href="#rid95">95-97</a>]. <a class="drug drug_general" data-topicid="9371" href="/d/drug information/9371.html" rel="external">Albendazole</a> treats common helminth infections; reduces the frequency of anemia in pregnancy, especially when added to iron supplementation; and appears to be safe when administered after the first trimester [<a href="#rid97">97</a>]. Additionally, antenatal treatment may improve postnatal outcome as infections during pregnancy have been associated with lower cognitive and gross motor functioning in offspring [<a href="#rid98">98</a>]. There is limited information on fetal effects of early pregnancy exposure, so use during the first trimester is not recommended. (See  <a class="medical medical_review" href="/d/html/487.html" rel="external">"Anthelminthic therapies", section on 'Albendazole'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9041" href="/d/drug information/9041.html" rel="external">Azithromycin</a> is another empiric anti-infective prenatal treatment that has shown promising results for reducing low birth weight and infant death [<a href="#rid99">99-104</a>].</p><p></p><p class="headingAnchor" id="H1700741363"><span class="h1">ASSESSING RESPONSE TO TREATMENT</span><span class="headingEndMark"> — </span>Mid-upper arm circumference (MUAC), weight, and/or body mass index (BMI) should be measured at each prenatal visit to monitor for recovery, depending on which criteria were used to diagnose malnutrition and recovery. Additionally, gestational weight gain should be monitored closely and compared with existing guidelines, such as the widely used National Academy of Medicine (formerly the Institute of Medicine [IOM]) guideline  (<a class="graphic graphic_table graphicRef75820" href="/d/graphic/75820.html" rel="external">table 1</a>) [<a href="#rid105">105,106</a>].</p><p>The National Academy of Medicine considers weekly maternal weight gain &lt;230 grams as slow (below average) [<a href="#rid4">4</a>], which can be used as a criterion for gauging response to treatment.</p><p>When MUAC is used to identify malnourished patients needing supplementation, United Nations High Commissioner for Refugees (UNHCR) suggests that supplemental feeding programs use MUAC ≥23 cm as the criterion for discharge from the feeding program [<a href="#rid94">94</a>]. When BMI is used as an entry criterion for a feeding program, a BMI &gt;18.5 kg/m<sup>2</sup> can be considered for discharge from the program. However, if resources allow, supplemental feeding should be continued until six months postpartum as nutrient demands remain high during this period of exclusive breastfeeding. (See <a class="local">'Low gestational weight gain'</a> above.)</p><p class="headingAnchor" id="H87511619"><span class="h1">MANAGEMENT OF TREATMENT FAILURE</span><span class="headingEndMark"> — </span>In most cases, therapy will be ineffective in alleviating undernutrition in pregnancy. As an example, a trial of supplemental food (900 kcal/day and 33 to 36 grams of protein/day) for pregnant Malawian patients with moderate malnutrition (mean mid-upper arm circumference [MUAC] 22.3 cm) reported that mean MUAC did not increase by the end of the study and overall weight gain was modest [<a href="#rid72">72</a>]. The patients received a mean five rations of the supplemental food over a period of 11.4 weeks from enrollment until delivery.</p><p>In cases of treatment failure, the clinician should reevaluate the patient, keeping in mind supplementary food is needed in wasting patients but may not be sufficient unless used in combination with other interventions:</p><p class="bulletIndent1"><span class="glyph">●</span>Reevaluate nutritional intake. Determine whether the patient is so poor that they have no<strong><em> </em></strong>other food. In such cases, the supplement is unlikely to be sufficient to help them recover and may need to be increased.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Assess for nonadherence. Confirm consumption of the supplemental food as it may be voluntarily shared with others or sold, stolen, or controlled by family members, individuals residing with the patient, or community members rather than the beneficiary.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluate for an ongoing inflammatory process, such as an abscess, a chronic pelvic or bone infection, intestinal helminths, or a large burden of placental malaria. In settings where diagnostic capabilities are limited, it may be prudent to simply treat for malaria or sexually transmitted infections as they are so common. (See  <a class="medical medical_review" href="/d/html/4812.html" rel="external">"Malaria in pregnancy: Prevention and treatment"</a> and  <a class="medical medical_review" href="/d/html/4795.html" rel="external">"Malaria in pregnancy: Epidemiology, clinical manifestations, diagnosis, and outcome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluate for a medical etiology of undernutrition. When a social etiology or inadequate nutritional intake is not identified, evaluation for HIV, tuberculosis, blood dyscrasias, malignancy, and other chronic conditions should be undertaken and may be facilitated by referral to an appropriate medical center with advanced diagnostic capabilities.</p><p></p><p class="headingAnchor" id="H1740819832"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/131874.html" rel="external">"Society guideline links: Nutrition and supplements in pregnancy"</a> and  <a class="medical medical_society_guidelines" href="/d/html/110738.html" rel="external">"Society guideline links: Pediatric malnutrition"</a>.)</p><p class="headingAnchor" id="H1162967734"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Importance of adequate nutrition</strong> – Adequate maternal nutrient intake is required to promote optimal growth of the fetus and favorable outcomes for the mother and infant. Undernutrition during pregnancy can result in fetal growth restriction, preterm birth, and low birth weight infants. (See <a class="local">'Consequences of maternal undernutrition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis of undernutrition</strong> – Undernutrition during pregnancy can be diagnosed based on a mid-upper arm circumference (MUAC) &lt;23 cm, body mass index (BMI) &lt;18.5 kg/m<sup>2</sup>, and/or gestational weight gain &lt;230 grams/week. (See <a class="local">'Anthropometric diagnosis of undernutrition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation of undernourished patients</strong> – The work-up of undernourished pregnant patients should include an evaluation of dietary intake and diversity, assessment of food insecurity, anthropometric assessment (eg, BMI, MUAC), evaluation for clinical instability, and examination for signs and symptoms of micronutrient deficiencies. The standard prenatal laboratory examination is based on local and national recommendations; additional laboratory tests are ordered based on suspicious clinical findings rather than undernutrition alone. (See <a class="local">'Evaluation for undernutrition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>When food is secure and available, the initial treatment approach involves nutritional education on energy-dense, locally available foods. In endemic areas, empiric treatment of helminthic infection reduces the risk for anemia. (See <a class="local">'Basic principles'</a> above and <a class="local">'Adjunctive therapies'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>When locally available foods are not sufficient to correct undernutrition, then balanced energy and protein supplements, fortified blended flours, lipid-based nutrient supplements, or multiple micronutrient supplements can be used to address both macronutrient and micronutrient deficiencies. (See <a class="local">'Use and types of supplements'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assessing response to treatment</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Response to treatment can be assessed by MUAC ≥23 cm, weight gain ≥230 grams/week, and/or BMI ≥18.5 kg/m<sup>2</sup>, depending on which criteria were used to diagnose undernutrition and recovery. If resources allow, supplemental feeding should be continued until six months postpartum. (See <a class="local">'Assessing response to treatment'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If recovery from undernutrition does not occur with treatment, dietary intake and use of supplemental food should be reassessed, and referral for in-depth work-up for underlying disease conditions should be undertaken. (See <a class="local">'Management of treatment failure'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Roberts CT, Sohlstrom A, Kind KL, et al. Maternal food restriction reduces the exchange surface area and increases the barrier thickness of the placenta in the guinea-pig. Placenta 2001; 22:177.</a></li><li><a class="nounderline abstract_t">Fowden AL, Ralph MM, Silver M. Nutritional regulation of uteroplacental prostaglandin production and metabolism in pregnant ewes and mares during late gestation. Exp Clin Endocrinol 1994; 102:212.</a></li><li><a class="nounderline abstract_t">Belkacemi L, Nelson DM, Desai M, Ross MG. Maternal undernutrition influences placental-fetal development. Biol Reprod 2010; 83:325.</a></li><li class="breakAll">Weight Gain During Pregnancy: Reexamining the Guidelines, Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines. (Ed), National Academies Press (US) 2009.</li><li><a class="nounderline abstract_t">Brabin BJ, Hakimi M, Pelletier D. An analysis of anemia and pregnancy-related maternal mortality. J Nutr 2001; 131:604S.</a></li><li><a class="nounderline abstract_t">Rush D. Nutrition and maternal mortality in the developing world. Am J Clin Nutr 2000; 72:212S.</a></li><li><a class="nounderline abstract_t">Sikder SS, Labrique AB, Shamim AA, et al. Risk factors for reported obstetric complications and near misses in rural northwest Bangladesh: analysis from a prospective cohort study. BMC Pregnancy Childbirth 2014; 14:347.</a></li><li><a class="nounderline abstract_t">Painter RC, Roseboom TJ, Bleker OP. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol 2005; 20:345.</a></li><li><a class="nounderline abstract_t">Hult M, Tornhammar P, Ueda P, et al. Hypertension, diabetes and overweight: looming legacies of the Biafran famine. PLoS One 2010; 5:e13582.</a></li><li class="breakAll">Edward M. The Barker Hypothesis. In: Handbook of Famine, Starvation, and Nutrient Deprivation, Preedy VR, Patel VB (Eds), Springer, New York 2017.</li><li><a class="nounderline abstract_t">Hsu CN, Tain YL. The Good, the Bad, and the Ugly of Pregnancy Nutrients and Developmental Programming of Adult Disease. Nutrients 2019; 11.</a></li><li class="breakAll">WHO Recommendations on Antenatal Care for a Positive Pregnancy Experience, World Health Organization, Geneva 2016.</li><li><a class="nounderline abstract_t">McCauley ME, van den Broek N, Dou L, Othman M. Vitamin A supplementation during pregnancy for maternal and newborn outcomes. Cochrane Database Syst Rev 2015; :CD008666.</a></li><li><a class="nounderline abstract_t">Hofmeyr GJ, Lawrie TA, Atallah ÁN, Torloni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2018; 10:CD001059.</a></li><li><a class="nounderline abstract_t">Jameson S. Zinc status in pregnancy: the effect of zinc therapy on perinatal mortality, prematurity, and placental ablation. Ann N Y Acad Sci 1993; 678:178.</a></li><li><a class="nounderline abstract_t">Caulfield LE, Zavaleta N, Shankar AH, Merialdi M. Potential contribution of maternal zinc supplementation during pregnancy to maternal and child survival. Am J Clin Nutr 1998; 68:499S.</a></li><li><a class="nounderline abstract_t">Ota E, Mori R, Middleton P, et al. Zinc supplementation for improving pregnancy and infant outcome. Cochrane Database Syst Rev 2015; :CD000230.</a></li><li><a class="nounderline abstract_t">Dreyfuss ML, Stoltzfus RJ, Shrestha JB, et al. Hookworms, malaria and vitamin A deficiency contribute to anemia and iron deficiency among pregnant women in the plains of Nepal. J Nutr 2000; 130:2527.</a></li><li><a class="nounderline abstract_t">Ververs MT, Antierens A, Sackl A, et al. Which anthropometric indicators identify a pregnant woman as acutely malnourished and predict adverse birth outcomes in the humanitarian context? PLoS Curr 2013; 5.</a></li><li><a class="nounderline abstract_t">Sultana T, Karim MN, Ahmed T, Hossain MI. Assessment of under nutrition of Bangladeshi adults using anthropometry: can body mass index be replaced by mid-upper-arm-circumference? PLoS One 2015; 10:e0121456.</a></li><li><a class="nounderline abstract_t">Hambidge KM, Krebs NF, Garcés A, et al. Anthropometric indices for non-pregnant women of childbearing age differ widely among four low-middle income populations. BMC Public Health 2017; 18:45.</a></li><li><a class="nounderline abstract_t">Elshibly EM, Schmalisch G. The effect of maternal anthropometric characteristics and social factors on gestational age and birth weight in Sudanese newborn infants. BMC Public Health 2008; 8:244.</a></li><li><a class="nounderline abstract_t">Assefa N, Berhane Y, Worku A. Wealth status, mid upper arm circumference (MUAC) and antenatal care (ANC) are determinants for low birth weight in Kersa, Ethiopia. PLoS One 2012; 7:e39957.</a></li><li class="breakAll">Tang AM, Chung M, Dong K, et al. Determining a Global Mid-Upper Arm Circumference Cutoff to Assess Malnutrition in Pregnant Women
. Fanta III, Food and Nutrition Technical Assistance. 2016. https://www.fantaproject.org/sites/default/files/resources/FANTA-MUAC-cutoffs-pregnant-women-June2016.pdf (Accessed on November 26, 2019).</li><li class="breakAll">The Sphere Handbook: Humanitarian Charter and Minimum Standards in Humanitarian Response, 4th ed, Geneva 2018.</li><li><a class="nounderline abstract_t">Nahar S, Mascie-Taylor CG, Begum HA. Impact of targeted food supplementation on pregnancy weight gain and birth weight in rural Bangladesh: an assessment of the Bangladesh Integrated Nutrition Program (BINP). Public Health Nutr 2009; 12:1205.</a></li><li><a class="nounderline abstract_t">Han Z, Mulla S, Beyene J, et al. Maternal underweight and the risk of preterm birth and low birth weight: a systematic review and meta-analyses. Int J Epidemiol 2011; 40:65.</a></li><li><a class="nounderline abstract_t">Girsen AI, Mayo JA, Carmichael SL, et al. Women's prepregnancy underweight as a risk factor for preterm birth: a retrospective study. BJOG 2016; 123:2001.</a></li><li><a class="nounderline abstract_t">Pugh SJ, Albert PS, Kim S, et al. Patterns of gestational weight gain and birthweight outcomes in the Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies-Singletons: a prospective study. Am J Obstet Gynecol 2017; 217:346.e1.</a></li><li><a class="nounderline abstract_t">Sridhar SB, Xu F, Hedderson MM. Trimester-Specific Gestational Weight Gain and Infant Size for Gestational Age. PLoS One 2016; 11:e0159500.</a></li><li><a class="nounderline abstract_t">Arora P, Tamber Aeri B. Gestational Weight Gain among Healthy Pregnant Women from Asia in Comparison with Institute of Medicine (IOM) Guidelines-2009: A Systematic Review. J Pregnancy 2019; 2019:3849596.</a></li><li><a class="nounderline abstract_t">Hutcheon JA, Platt RW, Abrams B, et al. A weight-gain-for-gestational-age z score chart for the assessment of maternal weight gain in pregnancy. Am J Clin Nutr 2013; 97:1062.</a></li><li><a class="nounderline abstract_t">Johansson K, Hutcheon JA, Stephansson O, Cnattingius S. Pregnancy weight gain by gestational age and BMI in Sweden: a population-based cohort study. Am J Clin Nutr 2016; 103:1278.</a></li><li><a class="nounderline abstract_t">Xu J, Luntamo M, Kulmala T, et al. A longitudinal study of weight gain in pregnancy in Malawi: unconditional and conditional standards. Am J Clin Nutr 2014; 99:296.</a></li><li class="breakAll">2020 Global Nutrition Report: Action on equity to end malnutrition. Global Nutrition Report. Available at: https://globalnutritionreport.org/documents/566/2020_Global_Nutrition_Report_2hrssKo.pdf (Accessed on August 10, 2021).</li><li class="breakAll">2018 Global Nutrition Report: Shining a light to spur action on nutrition, Development Initiatives, Bristol 2018.</li><li><a class="nounderline abstract_t">Desyibelew HD, Dadi AF. Burden and determinants of malnutrition among pregnant women in Africa: A systematic review and meta-analysis. PLoS One 2019; 14:e0221712.</a></li><li><a class="nounderline abstract_t">Victora CG, Christian P, Vidaletti LP, et al. Revisiting maternal and child undernutrition in low-income and middle-income countries: variable progress towards an unfinished agenda. Lancet 2021; 397:1388.</a></li><li><a class="nounderline abstract_t">Asefa F, Cummins A, Dessie Y, et al. Gestational weight gain and its effect on birth outcomes in sub-Saharan Africa: Systematic review and meta-analysis. PLoS One 2020; 15:e0231889.</a></li><li><a class="nounderline abstract_t">Hanson MA, Bardsley A, De-Regil LM, et al. The International Federation of Gynecology and Obstetrics (FIGO) recommendations on adolescent, preconception, and maternal nutrition: "Think Nutrition First". Int J Gynaecol Obstet 2015; 131 Suppl 4:S213.</a></li><li><a class="nounderline abstract_t">Johnson W, Moore SE. Adolescent pregnancy, nutrition, and health outcomes in low- and middle-income countries: what we know and what we don't know. BJOG 2016; 123:1589.</a></li><li><a class="nounderline abstract_t">Shinagawa S, Suzuki S, Chihara H, et al. Maternal basal metabolic rate in twin pregnancy. Gynecol Obstet Invest 2005; 60:145.</a></li><li class="breakAll">The State of Food Security and Nutrition in the World 2021: Transforming food systems for food security, improved nutrition and affordable healthy diets for all. Last updated July 23, 2021. Food and Agriculture Organization of the United Nations. (Available online at http://www.fao.org/3/cb4474en/online/cb4474en.html).</li><li class="breakAll">Nutrition During Pregnancy: Part I Weight Gain: Part II Nutrient Supplements, Institute of Medicine (US) Committee on Nutritional Status During Pregnancy and Lactation. (Ed), National Academies Press (US), Washington (DC) 1990.</li><li class="breakAll">Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline, Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline. (Eds), National Academies Press (US), Washington (DC) 1998.</li><li class="breakAll">Dietary Reference Intakes for Calcium and Vitamin D, Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. (Ed), National Academies Press (US), Washington (DC) 2011.</li><li class="breakAll">Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc, Institute of Medicine (US) Panel on Micronutrients. (Ed), National Academies Press (US), Washington (DC) 2001.</li><li class="breakAll">Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids, National Academies Press, Washington, DC 2000.</li><li class="breakAll">Essential Nutrition Actions: Improving Maternal, Newborn, Infant and Young Child Health and Nutrition, World Health Organization, Geneva 2013.</li><li class="breakAll">Preventing and controlling micronutrient deficiencies in populations affected by an emergency: Multiple vitamin and mineral supplements for pregnant and lactating women, and for children aged 6 to 59 months, UNICEF and the World Health Organization, Geneva 2007.</li><li class="breakAll">Von Grebmer K SA, Birol E, Wiesmann D, et al.. 2014 Global Hunger Index: The Challenge of Hidden Hunger, International Food Policy Research Institute and Concern Worldwide, Washington, DC 2014.</li><li><a class="nounderline abstract_t">Mousa A, Naqash A, Lim S. Macronutrient and Micronutrient Intake during Pregnancy: An Overview of Recent Evidence. Nutrients 2019; 11.</a></li><li><a class="nounderline abstract_t">McLean E, Cogswell M, Egli I, et al. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr 2009; 12:444.</a></li><li><a class="nounderline abstract_t">Stevens GA, Finucane MM, De-Regil LM, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Glob Health 2013; 1:e16.</a></li><li class="breakAll">Global prevalence of vitamin A deficiency in populations at risk 1995-2005. WHO global database on vitamin A deficiency. World Health Organization, Geneva 2009.</li><li class="breakAll">Coates J, Swindale A, Bilinsky P. Household Food Insecurity Access Scale (HFIAS) for Measurement of Household Food Access: Indicator Guide, 3rd ed, FHI 360 and Food and Nutrition Technical Assistance III Project (FANTA) Washington, DC 2007.</li><li><a class="nounderline abstract_t">Ota E, Hori H, Mori R, et al. Antenatal dietary education and supplementation to increase energy and protein intake. Cochrane Database Syst Rev 2015; :CD000032.</a></li><li><a class="nounderline abstract_t">da Silva Lopes K, Ota E, Shakya P, et al. Effects of nutrition interventions during pregnancy on low birth weight: an overview of systematic reviews. BMJ Glob Health 2017; 2:e000389.</a></li><li><a class="nounderline abstract_t">Dhaded SM, Hambidge KM, Ali SA, et al. Preconception nutrition intervention improved birth length and reduced stunting and wasting in newborns in South Asia: The Women First Randomized Controlled Trial. PLoS One 2020; 15:e0218960.</a></li><li><a class="nounderline abstract_t">Lassi ZS, Padhani ZA, Rabbani A, et al. Impact of Dietary Interventions during Pregnancy on Maternal, Neonatal, and Child Outcomes in Low- and Middle-Income Countries. Nutrients 2020; 12.</a></li><li><a class="nounderline abstract_t">Yang Z, Huffman SL. Review of fortified food and beverage products for pregnant and lactating women and their impact on nutritional status. Matern Child Nutr 2011; 7 Suppl 3:19.</a></li><li class="breakAll">Food and Nutrition Needs in Emergencies. Technical document of the WHO, UNHCR, UNICEF, and WFP 2003.</li><li class="breakAll">Reginald AA, Webb P, Brown R. Management of moderate acute malnutrition (MAM): current knowledge and practice. CMAM Forum Technical Brief 2014.</li><li><a class="nounderline abstract_t">Janmohamed A, Karakochuk CD, Boungnasiri S, et al. Prenatal supplementation with Corn Soya Blend Plus reduces the risk of maternal anemia in late gestation and lowers the rate of preterm birth but does not significantly improve maternal weight gain and birth anthropometric measurements in rural Cambodian women: a randomized trial. Am J Clin Nutr 2016; 103:559.</a></li><li><a class="nounderline abstract_t">Saville NM, Shrestha BP, Style S, et al. Impact on birth weight and child growth of Participatory Learning and Action women's groups with and without transfers of food or cash during pregnancy: Findings of the low birth weight South Asia cluster-randomised controlled trial (LBWSAT) in Nepal. PLoS One 2018; 13:e0194064.</a></li><li class="breakAll">World Food Programme. Nutrition at the World Food Programme: Programming for Nutrition-Specific Interventions. Rome: December 2012.</li><li><a class="nounderline abstract_t">Das JK, Hoodbhoy Z, Salam RA, et al. Lipid-based nutrient supplements for maternal, birth, and infant developmental outcomes. Cochrane Database Syst Rev 2018; 8:CD012610.</a></li><li><a class="nounderline abstract_t">Goto E. Effectiveness of Prenatal Lipid-Based Nutrient Supplementation to Improve Birth Outcomes: A Meta-analysis. Am J Trop Med Hyg 2019; 101:994.</a></li><li><a class="nounderline abstract_t">Ashorn P, Alho L, Ashorn U, et al. The impact of lipid-based nutrient supplement provision to pregnant women on newborn size in rural Malawi: a randomized controlled trial. Am J Clin Nutr 2015; 101:387.</a></li><li><a class="nounderline abstract_t">Adu-Afarwuah S, Lartey A, Okronipa H, et al. Small-quantity, lipid-based nutrient supplements provided to women during pregnancy and 6 mo postpartum and to their infants from 6 mo of age increase the mean attained length of 18-mo-old children in semi-urban Ghana: a randomized controlled trial. Am J Clin Nutr 2016; 104:797.</a></li><li><a class="nounderline abstract_t">Mridha MK, Matias SL, Chaparro CM, et al. Lipid-based nutrient supplements for pregnant women reduce newborn stunting in a cluster-randomized controlled effectiveness trial in Bangladesh. Am J Clin Nutr 2016; 103:236.</a></li><li><a class="nounderline abstract_t">Callaghan-Gillespie M, Schaffner AA, Garcia P, et al. Trial of ready-to-use supplemental food and corn-soy blend in pregnant Malawian women with moderate malnutrition: a randomized controlled clinical trial. Am J Clin Nutr 2017; 106:1062.</a></li><li><a class="nounderline abstract_t">Adu-Afarwuah S, Lartey A, Okronipa H, et al. Lipid-based nutrient supplement increases the birth size of infants of primiparous women in Ghana. Am J Clin Nutr 2015; 101:835.</a></li><li><a class="nounderline abstract_t">Isanaka S, Kodish SR, Mamaty AA, et al. Acceptability and utilization of a lipid-based nutrient supplement formulated for pregnant women in rural Niger: a multi-methods study. BMC Nutr 2019; 5:34.</a></li><li><a class="nounderline abstract_t">Hambidge KM, Westcott JE, Garcés A, et al. A multicountry randomized controlled trial of comprehensive maternal nutrition supplementation initiated before conception: the Women First trial. Am J Clin Nutr 2019; 109:457.</a></li><li><a class="nounderline abstract_t">Oh C, Keats EC, Bhutta ZA. Vitamin and Mineral Supplementation During Pregnancy on Maternal, Birth, Child Health and Development Outcomes in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. Nutrients 2020; 12.</a></li><li class="breakAll">Composition of a multi-micronutrient supplement to be used in pilot programmes among pregnant women in developing countries: report of a United Nations Children's Fund (‎UNICEF)‎, World Health Organization (‎WHO)‎ and United Nations University workshop, UNICEF, New York 1999.</li><li><a class="nounderline abstract_t">Keats EC, Haider BA, Tam E, Bhutta ZA. Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database Syst Rev 2019; 3:CD004905.</a></li><li><a class="nounderline abstract_t">Vaidya A, Saville N, Shrestha BP, et al. Effects of antenatal multiple micronutrient supplementation on children's weight and size at 2 years of age in Nepal: follow-up of a double-blind randomised controlled trial. Lancet 2008; 371:492.</a></li><li><a class="nounderline abstract_t">Okala SG, Darboe MK, Sosseh F, et al. Impact of nutritional supplementation during pregnancy on antibody responses to diphtheria-tetanus-pertussis vaccination in infants: A randomised trial in The Gambia. PLoS Med 2019; 16:e1002854.</a></li><li class="breakAll">WHO antenatal care recommendations for a positive pregnancy experience. Nutritional interventions update: Multiple micronutrient supplements during pregnancy. Last updated July 26, 2020. World Health Organization. (Available online at: https://www.who.int/publications/i/item/9789240007789).</li><li><a class="nounderline abstract_t">Lassi ZS, Kedzior SG, Tariq W, et al. Effects of Preconception Care and Periconception Interventions on Maternal Nutritional Status and Birth Outcomes in Low- and Middle-Income Countries: A Systematic Review. Nutrients 2020; 12.</a></li><li><a class="nounderline abstract_t">Jonker H, Capelle N, Lanes A, et al. Maternal folic acid supplementation and infant birthweight in low- and middle-income countries: A systematic review. Matern Child Nutr 2020; 16:e12895.</a></li><li><a class="nounderline abstract_t">Guo H, Mao B, Wang M, et al. Folic acid supplementation, dietary folate intake and risk of small for gestational age in China. Public Health Nutr 2020; 23:1965.</a></li><li class="breakAll">WHO antenatal care recommendations for a positive pregnancy experience. Nutritional interventions update: Vitamin D supplements during pregnancy. Last updated July 29, 2020. World Health Organization. (Available online at https://www.who.int/publications/i/item/9789240008120).</li><li><a class="nounderline abstract_t">Dorniak-Wall T, Grivell RM, Dekker GA, et al. The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials. J Hum Hypertens 2014; 28:230.</a></li><li><a class="nounderline abstract_t">Weckman AM, McDonald CR, Baxter JB, et al. Perspective: L-arginine and L-citrulline Supplementation in Pregnancy: A Potential Strategy to Improve Birth Outcomes in Low-Resource Settings. Adv Nutr 2019; 10:765.</a></li><li><a class="nounderline abstract_t">Visek WJ. Arginine needs, physiological state and usual diets. A reevaluation. J Nutr 1986; 116:36.</a></li><li><a class="nounderline abstract_t">McNeal CJ, Meininger CJ, Reddy D, et al. Safety and Effectiveness of Arginine in Adults. J Nutr 2016; 146:2587S.</a></li><li><a class="nounderline abstract_t">McNeal CJ, Meininger CJ, Wilborn CD, et al. Safety of dietary supplementation with arginine in adult humans. Amino Acids 2018; 50:1215.</a></li><li><a class="nounderline abstract_t">Grimble GK. Adverse gastrointestinal effects of arginine and related amino acids. J Nutr 2007; 137:1693S.</a></li><li><a class="nounderline abstract_t">Middleton P, Gomersall JC, Gould JF, et al. Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst Rev 2018; 11:CD003402.</a></li><li class="breakAll">Marine oil supplementation during pregnancy. World Health Organization. Available at: https://www.who.int/elena/titles/fish_oil_pregnancy/en/ (Accessed on August 05, 2021).</li><li class="breakAll">The UN Refugee Agency (UNHCR). Guidelines for Selective Feeding: The Management of Malnutrition in Emergencies. January 2011. https://www.unhcr.org/en-us/publications/operations/4b7421fd20/guidelines-selective-feeding-management-malnutrition-emergencies.html (Accessed on August 07, 2019).</li><li><a class="nounderline abstract_t">Christian P, Khatry SK, West KP Jr. Antenatal anthelmintic treatment, birthweight, and infant survival in rural Nepal. Lancet 2004; 364:981.</a></li><li><a class="nounderline abstract_t">Torlesse H, Hodges M. Anthelminthic treatment and haemoglobin concentrations during pregnancy. Lancet 2000; 356:1083.</a></li><li><a class="nounderline abstract_t">Torlesse H, Hodges M. Albendazole therapy and reduced decline in haemoglobin concentration during pregnancy (Sierra Leone). Trans R Soc Trop Med Hyg 2001; 95:195.</a></li><li><a class="nounderline abstract_t">Mireku MO, Boivin MJ, Davidson LL, et al. Impact of helminth infection during pregnancy on cognitive and motor functions of one-year-old children. PLoS Negl Trop Dis 2015; 9:e0003463.</a></li><li><a class="nounderline abstract_t">Hendrixson DT, Smith K, Lasowski P, et al. A novel intervention combining supplementary food and infection control measures to improve birth outcomes in undernourished pregnant women in Sierra Leone: A randomized, controlled clinical effectiveness trial. PLoS Med 2021; 18:e1003618.</a></li><li><a class="nounderline abstract_t">Luntamo M, Kulmala T, Cheung YB, et al. The effect of antenatal monthly sulphadoxine-pyrimethamine, alone or with azithromycin, on foetal and neonatal growth faltering in Malawi: a randomised controlled trial. Trop Med Int Health 2013; 18:386.</a></li><li><a class="nounderline abstract_t">Gray RH, Wabwire-Mangen F, Kigozi G, et al. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol 2001; 185:1209.</a></li><li><a class="nounderline abstract_t">Unger HW, Ome-Kaius M, Wangnapi RA, et al. Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial. BMC Med 2015; 13:9.</a></li><li><a class="nounderline abstract_t">Keenan JD, Bailey RL, West SK, et al. Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa. N Engl J Med 2018; 378:1583.</a></li><li><a class="nounderline abstract_t">Sie A, Bountogo M, Nebie E, et al. Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial. BMJ Open 2019; 9:e031162.</a></li><li><a class="nounderline abstract_t">Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995; 854:1.</a></li><li class="breakAll">WHO Technical Report Series. Physical status: The use and interpretation of anthropometry. https://apps.who.int/iris/bitstream/handle/10665/37003/WHO_TRS_854.pdf?sequence=1 (Accessed on November 26, 2019).</li></ol></div><div id="topicVersionRevision">Topic 122096 Version 12.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11170822" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Maternal food restriction reduces the exchange surface area and increases the barrier thickness of the placenta in the guinea-pig.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7995343" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Nutritional regulation of uteroplacental prostaglandin production and metabolism in pregnant ewes and mares during late gestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20445129" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Maternal undernutrition influences placental-fetal development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20445129" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Maternal undernutrition influences placental-fetal development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11160593" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : An analysis of anemia and pregnancy-related maternal mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10871588" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Nutrition and maternal mortality in the developing world.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25282340" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Risk factors for reported obstetric complications and near misses in rural northwest Bangladesh: analysis from a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15893910" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Prenatal exposure to the Dutch famine and disease in later life: an overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21042579" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Hypertension, diabetes and overweight: looming legacies of the Biafran famine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21042579" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Hypertension, diabetes and overweight: looming legacies of the Biafran famine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31010060" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The Good, the Bad, and the Ugly of Pregnancy Nutrients and Developmental Programming of Adult Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31010060" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The Good, the Bad, and the Ugly of Pregnancy Nutrients and Developmental Programming of Adult Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26503498" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Vitamin A supplementation during pregnancy for maternal and newborn outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30277579" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8494261" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Zinc status in pregnancy: the effect of zinc therapy on perinatal mortality, prematurity, and placental ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9701168" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Potential contribution of maternal zinc supplementation during pregnancy to maternal and child survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25927101" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Zinc supplementation for improving pregnancy and infant outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11015485" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Hookworms, malaria and vitamin A deficiency contribute to anemia and iron deficiency among pregnant women in the plains of Nepal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23787989" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Which anthropometric indicators identify a pregnant woman as acutely malnourished and predict adverse birth outcomes in the humanitarian context?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25875397" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Assessment of under nutrition of Bangladeshi adults using anthropometry: can body mass index be replaced by mid-upper-arm-circumference?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28738791" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Anthropometric indices for non-pregnant women of childbearing age differ widely among four low-middle income populations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18638377" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The effect of maternal anthropometric characteristics and social factors on gestational age and birth weight in Sudanese newborn infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22792140" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Wealth status, mid upper arm circumference (MUAC) and antenatal care (ANC) are determinants for low birth weight in Kersa, Ethiopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22792140" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Wealth status, mid upper arm circumference (MUAC) and antenatal care (ANC) are determinants for low birth weight in Kersa, Ethiopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22792140" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Wealth status, mid upper arm circumference (MUAC) and antenatal care (ANC) are determinants for low birth weight in Kersa, Ethiopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18838027" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Impact of targeted food supplementation on pregnancy weight gain and birth weight in rural Bangladesh: an assessment of the Bangladesh Integrated Nutrition Program (BINP).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21097954" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Maternal underweight and the risk of preterm birth and low birth weight: a systematic review and meta-analyses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27172996" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Women's prepregnancy underweight as a risk factor for preterm birth: a retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28502760" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Patterns of gestational weight gain and birthweight outcomes in the Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Studies-Singletons: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27442137" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Trimester-Specific Gestational Weight Gain and Infant Size for Gestational Age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30941218" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Gestational Weight Gain among Healthy Pregnant Women from Asia in Comparison with Institute of Medicine (IOM) Guidelines-2009: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23466397" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : A weight-gain-for-gestational-age z score chart for the assessment of maternal weight gain in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27009753" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Pregnancy weight gain by gestational age and BMI in Sweden: a population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24225354" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : A longitudinal study of weight gain in pregnancy in Malawi: unconditional and conditional standards.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24225354" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : A longitudinal study of weight gain in pregnancy in Malawi: unconditional and conditional standards.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24225354" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : A longitudinal study of weight gain in pregnancy in Malawi: unconditional and conditional standards.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31490956" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Burden and determinants of malnutrition among pregnant women in Africa: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33691094" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Revisiting maternal and child undernutrition in low-income and middle-income countries: variable progress towards an unfinished agenda.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32324783" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Gestational weight gain and its effect on birth outcomes in sub-Saharan Africa: Systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26433230" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The International Federation of Gynecology and Obstetrics (FIGO) recommendations on adolescent, preconception, and maternal nutrition: "Think Nutrition First".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26629786" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Adolescent pregnancy, nutrition, and health outcomes in low- and middle-income countries: what we know and what we don't know.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15925892" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Maternal basal metabolic rate in twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15925892" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Maternal basal metabolic rate in twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15925892" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Maternal basal metabolic rate in twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15925892" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Maternal basal metabolic rate in twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15925892" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Maternal basal metabolic rate in twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15925892" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Maternal basal metabolic rate in twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15925892" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Maternal basal metabolic rate in twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15925892" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Maternal basal metabolic rate in twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15925892" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Maternal basal metabolic rate in twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15925892" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Maternal basal metabolic rate in twin pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30791647" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Macronutrient and Micronutrient Intake during Pregnancy: An Overview of Recent Evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18498676" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25103581" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25103581" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25103581" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26031211" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Antenatal dietary education and supplementation to increase energy and protein intake.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29018583" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Effects of nutrition interventions during pregnancy on low birth weight: an overview of systematic reviews.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31995570" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Preconception nutrition intervention improved birth length and reduced stunting and wasting in newborns in South Asia: The Women First Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32092933" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Impact of Dietary Interventions during Pregnancy on Maternal, Neonatal, and Child Outcomes in Low- and Middle-Income Countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21929634" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Review of fortified food and beverage products for pregnant and lactating women and their impact on nutritional status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21929634" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Review of fortified food and beverage products for pregnant and lactating women and their impact on nutritional status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21929634" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Review of fortified food and beverage products for pregnant and lactating women and their impact on nutritional status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26739037" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Prenatal supplementation with Corn Soya Blend Plus reduces the risk of maternal anemia in late gestation and lowers the rate of preterm birth but does not significantly improve maternal weight gain and birth anthropometric measurements in rural Cambodian women: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29742136" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Impact on birth weight and child growth of Participatory Learning and Action women's groups with and without transfers of food or cash during pregnancy: Findings of the low birth weight South Asia cluster-randomised controlled trial (LBWSAT) in Nepal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29742136" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Impact on birth weight and child growth of Participatory Learning and Action women's groups with and without transfers of food or cash during pregnancy: Findings of the low birth weight South Asia cluster-randomised controlled trial (LBWSAT) in Nepal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30168868" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Lipid-based nutrient supplements for maternal, birth, and infant developmental outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31516104" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Effectiveness of Prenatal Lipid-Based Nutrient Supplementation to Improve Birth Outcomes: A Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25646337" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : The impact of lipid-based nutrient supplement provision to pregnant women on newborn size in rural Malawi: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27534634" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Small-quantity, lipid-based nutrient supplements provided to women during pregnancy and 6 mo postpartum and to their infants from 6 mo of age increase the mean attained length of 18-mo-old children in semi-urban Ghana: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26607935" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Lipid-based nutrient supplements for pregnant women reduce newborn stunting in a cluster-randomized controlled effectiveness trial in Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28793991" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Trial of ready-to-use supplemental food and corn-soy blend in pregnant Malawian women with moderate malnutrition: a randomized controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25833980" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Lipid-based nutrient supplement increases the birth size of infants of primiparous women in Ghana.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32153947" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Acceptability and utilization of a lipid-based nutrient supplement formulated for pregnant women in rural Niger: a multi-methods study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30721941" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : A multicountry randomized controlled trial of comprehensive maternal nutrition supplementation initiated before conception: the Women First trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32075071" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Vitamin and Mineral Supplementation During Pregnancy on Maternal, Birth, Child Health and Development Outcomes in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32075071" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Vitamin and Mineral Supplementation During Pregnancy on Maternal, Birth, Child Health and Development Outcomes in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30873598" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Multiple-micronutrient supplementation for women during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18262041" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Effects of antenatal multiple micronutrient supplementation on children's weight and size at 2 years of age in Nepal: follow-up of a double-blind randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31386660" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Impact of nutritional supplementation during pregnancy on antibody responses to diphtheria-tetanus-pertussis vaccination in infants: A randomised trial in The Gambia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31386660" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Impact of nutritional supplementation during pregnancy on antibody responses to diphtheria-tetanus-pertussis vaccination in infants: A randomised trial in The Gambia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32110886" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Effects of Preconception Care and Periconception Interventions on Maternal Nutritional Status and Birth Outcomes in Low- and Middle-Income Countries: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31680411" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Maternal folic acid supplementation and infant birthweight in low- and middle-income countries: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31787119" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Folic acid supplementation, dietary folate intake and risk of small for gestational age in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31787119" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Folic acid supplementation, dietary folate intake and risk of small for gestational age in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24172291" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31075164" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Perspective: L-arginine and L-citrulline Supplementation in Pregnancy: A Potential Strategy to Improve Birth Outcomes in Low-Resource Settings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3080558" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Arginine needs, physiological state and usual diets. A reevaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27934649" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Safety and Effectiveness of Arginine in Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29858688" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Safety of dietary supplementation with arginine in adult humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17513449" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Adverse gastrointestinal effects of arginine and related amino acids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30480773" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Omega-3 fatty acid addition during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30480773" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Omega-3 fatty acid addition during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30480773" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Omega-3 fatty acid addition during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15364190" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Antenatal anthelmintic treatment, birthweight, and infant survival in rural Nepal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11009150" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Anthelminthic treatment and haemoglobin concentrations during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11355560" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Albendazole therapy and reduced decline in haemoglobin concentration during pregnancy (Sierra Leone).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25756357" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Impact of helminth infection during pregnancy on cognitive and motor functions of one-year-old children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34582451" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : A novel intervention combining supplementary food and infection control measures to improve birth outcomes in undernourished pregnant women in Sierra Leone: A randomized, controlled clinical effectiveness trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23432801" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : The effect of antenatal monthly sulphadoxine-pyrimethamine, alone or with azithromycin, on foetal and neonatal growth faltering in Malawi: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11717659" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25591391" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29694816" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31488494" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8594834" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
